Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NAPOLEON Study)

NCT07218666 is registered in ClinicalTrials.gov with Deepak Kilari as lead sponsor.

NCT NCT07218666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07218666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NAPOLEON Study)
Lead sponsor
Deepak Kilari
Phase
Phase 2
Overall status
Recruiting
Start date
August 19, 2026
Completion date
July 31, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive variant prostate carcinoma